US 11813314
Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
granted A61KA61K31/155A61K38/31
Quick answer
US patent 11813314 (Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rani Therapeutics, LLC
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/155, A61K38/31, A61K9/0053, A61K9/4808